(Q79372143)
Statements
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancer (English)
Robert Coleman
Alessandro Minisini
Anne Hamilton
Matti Aapro
Patrick Therasse
Giuseppe Mottino
Jan Bogaerts
Martine Piccart
20 November 2006